|
VEGF blockade and alternative angiogenic pathways in neuroblastoma
|
3R01CA124644-05S1
|
$37,627
|
$37,627
|
YAMASHIRO, DARRELL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
VEGF blockade and alternative angiogenic pathways in neuroblastoma
|
5R01CA124644-05
|
$324,053
|
$324,053
|
YAMASHIRO, DARRELL
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S3
|
$4,555,705
|
$136,671
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S4
|
$74,854
|
$2,246
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S5
|
$139,989
|
$4,200
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-37S1
|
$50,000
|
$4,500
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-37S2
|
$246,000
|
$22,140
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-37S3
|
$74,999
|
$6,750
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-37
|
$6,285,726
|
$565,715
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Tumor-produced TNF alpha as an inducer of immune resistance and tumor survival
|
5R01CA136663-03
|
$330,091
|
$330,091
|
Levitskaia, Elena
|
JOHNS HOPKINS UNIVERSITY
|
|
Tumor Microenvironment in Cancer Progression
|
ZIABC011332
|
$343,873
|
$30,949
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Tulane Medical/Cancer Center Minority-Based Community Clinical Oncology Program
|
1U10CA167782-01
|
$700,000
|
$14,000
|
ROBINSON, WILLIAM
|
TULANE UNIVERSITY OF LOUISIANA
|
|
Trk Expression and Inhibition in Human Neuroblastomas
|
5R01CA094194-10
|
$366,503
|
$366,503
|
BRODEUR, GARRETT
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Tri-modal Polymeric Micelles for 'See & Treat' Applications in Surgical Oncology
|
5R21CA161537-02
|
$174,711
|
$174,711
|
KWON, GLEN
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Translational Genomics of MicroRNAs in Neuroblastoma
|
5K08CA136979-04
|
$161,773
|
$161,773
|
Cole, Kristina
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Topic 276-"Chemolieve: Differential protection of normal versus cancer cells in p
|
N44CO120051-000
|
$1,499,963
|
$299,993
|
MORGAN, TODD
|
L-NUTRA INC.
|
|
The Role of Stroma-derived Soluble TbetaRIII in Neuroblastoma
|
1F30CA168043-01
|
$47,232
|
$47,232
|
Knelson, Erik
|
DUKE UNIVERSITY
|
|
The Role of KIR and FcR Genotype in the Efficacy of mAb and IL2 Immunotherapy
|
1R01CA166105-01
|
$339,250
|
$203,550
|
SONDEL, PAUL
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
The Role of DNMT3B in the DNA Methylation of Cancer Cells
|
5R01CA129831-05
|
$350,219
|
$115,572
|
GODLEY, LUCY
|
UNIVERSITY OF CHICAGO
|
|
The Role of Caspase-8 in Neuroblastoma Tumorigenesis
|
5R01CA067938-14
|
$383,429
|
$383,429
|
ZAMBETTI, GERARD
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
The Genetic Basis of Neuroblastoma Tumorigenesis
|
5R01CA124709-05
|
$602,864
|
$602,864
|
MARIS, JOHN
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
The ALK receptor tyrosine kinase as a therapeutic target in neuroblastoma
|
5R01CA148688-02
|
$363,125
|
$363,125
|
GEORGE, RANI
|
DANA-FARBER CANCER INSTITUTE
|
|
Targeting Oncogenic ALK Signaling in Neuroblastoma
|
5R01CA140198-04
|
$331,098
|
$331,098
|
Mosse, YAEL
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Targeting High-risk Neuroblastoma using high through put siRNA screening
|
ZIABC010806
|
$287,376
|
$201,163
|
Khan, Javed
|
CCR (NCI)
|
|
Systems Biology of Tumor Progression and Drug Resistance
|
1U01CA168426-01
|
$1,211,593
|
$1,211,593
|
CALIFANO, ANDREA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Synthetic Cell Surface Receptors for Anticancer Drug Delivery
|
5R01CA083831-12
|
$232,058
|
$58,015
|
PETERSON, BLAKE
|
UNIVERSITY OF KANSAS LAWRENCE
|
|
Support for Human Specimen Banking in NCI-Sponsored Clinical Trials-(CGB)
|
3U24CA114766-07S1
|
$499,863
|
$99,973
|
RAMIREZ, NILSA
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
Support for Human Specimen Banking in NCI-Sponsored Clinical Trials-(CGB)
|
3U24CA114766-07S2
|
$1,488,625
|
$297,725
|
RAMIREZ, NILSA
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
Support for Human Specimen Banking in NCI-Sponsored Clinical Trials-(CGB)
|
7U24CA114766-07
|
$1,329,162
|
$265,832
|
RAMIREZ, NILSA
|
RESEARCH INST NATIONWIDE CHILDREN'S HOSP
|
|
St. Vincent Hospital Regional Cancer Center CCOP
|
5U10CA095968-11
|
$835,168
|
$16,703
|
SAPHNER, THOMAS
|
ST. VINCENT HOSPITAL
|
|
ST Louis-Cape Girardeau CCOP
|
3U10CA035128-28S1
|
$421,379
|
$8,428
|
Sleckman, Bethany
|
ST. JOHN'S MERCY MEDICAL CENTER
|
|
Sphingosine-1-Phosphate Pathway Based Therapy for Neuroblastoma
|
1R01CA168903-01
|
$358,902
|
$358,902
|
FERRER, FERNANDO
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-27S6
|
$3,781,672
|
$37,817
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA AT SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-27S7
|
$200,699
|
$2,007
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA AT SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-27S8
|
$625,000
|
$6,250
|
LIPPMAN, SCOTT
|
UNIVERSITY OF CALIFORNIA AT SAN DIEGO
|
|
South Texas Pediatric Minority Based CCOP
|
5U10CA052771-22
|
$426,822
|
$34,146
|
LANGEVIN, ANNE-MARIE
|
UNIV OF TX HSC, SA
|
|
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
|
ZIABC010958
|
$448,460
|
$44,846
|
Daar, Ira
|
CCR (NCI)
|
|
Role of Trk Receptors in the Development and Function of Non-neuronal Structures
|
ZIABC010391
|
$539,792
|
$53,979
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Role of the SCF/Fbxo15 ubiquitin ligase in stem cells and cancer biology
|
5R21CA161108-02
|
$183,788
|
$60,650
|
PAGANO, MICHELE
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Role of Neurotrophins in the Development of the Mammalian Nervous System
|
ZIABC010390
|
$539,792
|
$107,958
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Role of gangliosides in tumor progression
|
5R01CA061010-17
|
$331,222
|
$82,806
|
LADISCH, STEPHAN
|
CHILDREN'S RESEARCH INSTITUTE
|
|
RGB-286638 as a radiation sensitizer
|
ZIABC011454
|
$181,701
|
$45,425
|
Haglund, Karl
|
CCR (NCI)
|
|
Reverse ChIP: Sequence-specific extraction of DNA-bound histones for analysis of
|
1R43CA159883-01A1
|
$295,222
|
$295,222
|
Dapprich, Johannes
|
GENERATION BIOTECH, LLC
|
|
Research Management and Support - Total
|
RMS2012 [E]
|
$374,919,382
|
$86,231
|
N/A
|
(NCI)
|
|
Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma
|
ZIABC010788
|
$463,931
|
$278,359
|
Thiele, Carol
|
CCR (NCI)
|
|
Regional Oncology Research Center
|
2P30CA006973-49
|
$6,995,267
|
$69,953
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-49S1
|
$75,000
|
$750
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-49S2
|
$50,000
|
$500
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Radiological Physics Center
|
5U10CA010953-44
|
$2,388,541
|
$71,656
|
Followill, David
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Quantitative SPECT for Targeted Radionuclide Therapy
|
5R01CA109234-07
|
$392,874
|
$98,219
|
FREY, ERIC
|
JOHNS HOPKINS UNIVERSITY
|
Total relevant funding to Neuroblastoma for this search: $27,138,562
|